コンテンツへスキップ
Merck

791649C

Avanti

18:1-d9 SM

Avanti Research - A Croda Brand

別名:

N-oleoyl(d9)-D-erythro-sphingosylphosphorylcholine

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

実験式(ヒル表記法):
C41H72 D9N2O6P
CAS番号:
分子量:
738.12
MDL number:
NACRES:
NA.25
UNSPSC Code:
41141825
Assay:
>99% (TLC)
Form:
liquid
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


assay

>99% (TLC)

form

liquid

packaging

pkg of 1 × 1 mL (791649C-1mg)

manufacturer/tradename

Avanti Research - A Croda Brand

concentration

1 mg/mL (791649C-1mg)

shipped in

dry ice

storage temp.

−20°C

General description

18:1-d9 SM (N-oleoyl(d9)-D-erythro-sphingosylphosphorylcholine) is a deuterated derivative of 18:1-SM (N-oleoyl-D-erythro-sphingosylphosphorylcholine). 18:1- SM is a sphingomyelin which is present in aqueous humor. 18:1-SM or oleoyl-sphingomyelin, comprises quaternary ammonium group. 18:1-SM or oleoyl-sphingomyelin due to its miscible property is incapable of sequestering with cholesterol-rich domains.
This deuterium labeled lipid is also available in a formulation of multiple lipid standards. The SPLASH LIPIDOMIX Standard includes all of the major lipid classes at ratios relative to human plasma, allowing one easy internal standard solution to be added to every sample.

Application

18:1-d9 SM (N-oleoyl(d9)-D-erythro-sphingosylphosphorylcholine) has been used as an extraction buffer component for lipid isolation from raft and non-raft fractions of synaptic vesicles (SV) from rat brain. It may be used as an internal standard to spike serum lipid extracts for liquid chromatography-mass spectrometry (LC/MS) analysis and ultra-high-performance supercritical fluid chromatography with quadrupole-time-of-flight mass spectrometry (UHPSFC/QTOF-MS) for signal normalization and quantification of pulmonary artery lipids form porcine.

Packaging

5 mL Clear Glass Sealed Ampule (791649C-1mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC
LIPIDOMIX is a trademark of Avanti Polar Lipids, LLC
SPLASH is a trademark of Avanti Polar Lipids, LLC


pictograms

Skull and crossbonesHealth hazard

signalword

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

target_organs

Central nervous system, Liver,Kidney

保管分類

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

wgk

WGK 3

flash_point_f

does not flash

flash_point_c

does not flash


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Class I Designated Chemical Substances

prtr

Substances Subject to be Indicated Names

ishl_indicated

Substances Subject to be Notified Names

ishl_notified

791649C-1MG:4.548173357799E12

jan



最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 資料 section.

サポートが必要な場合は、お問い合わせください カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする



Ayman J Aljohani et al.
Molecular vision, 19, 1966-1984 (2013-09-27)
To determine the differential profiles of sphingomyelin, sphingoid base, sphingoid base-1-phosphate and ceramide lipid species and their quantitative differences between control and glaucomatous aqueous humor (AQH) derived from human donors. AQH from control and primary open-angle glaucoma donors was collected
John Williams et al.
Bioanalysis, 12(3), 143-158 (2020-02-14)
Aim: Very long chain fatty acids (VLCFAs) have been identified as biomarkers for several peroxisomal disorders necessitating the need for reliable biomarker assays in particular C20, C22, C24, C26 in cerebrospinal fluid (CSF). Until now no absolute quantitation assay for
Michael S Gardner et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1118-1119, 137-147 (2019-04-30)
Progress toward better diagnosis and treatment of lipid metabolism-related diseases requires high throughput approaches for multiplexed quantitative analysis of structurally diverse lipids, including phospholipids (PLs). This work demonstrates a simplified "one-pot" phospholipid extraction protocol, as an alternative to conventional liquid-liquid